Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Share News (TRX)

Share Price Information for Tissue Regenix Group (TRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.00
Bid: 68.00
Ask: 70.00
Change: 0.00 (0.00%)
Spread: 2.00 (2.941%)
Open: 69.00
High: 69.00
Low: 69.00
Prev. Close: 69.00
TRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Marlowe Poaches From Fullers; RM Promotes To CEO

Fri, 26th Feb 2021 17:14

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and Friday and not separately reported by Alliance News:

----------

Marlowe PLC - London-based safety and compliance services and software - Hires Adam Councell as chief financial officer. Councell is finance director of pub and hotel chain Fuller, Smith & Turner PLC. Fullers says that Councell will stay on the board as finance director until a successor has been found and that a search is underway. Marlowe says Councell will join in the second half of its 2022 financial year, meaning October 2021 to March 2022. Councell was CFO at document management company Restore PLC, where he worked with Marlowe Chief Executive Alex Dacre. Prior to that, he was with pest control firm Rentokil Initial PLC. At Marlowe, Councell will replace Mark Adams, who is retiring.

----------

RM PLC - Abingdon, England-based provider of technology and resources to education sector - Promotes CFO Neil Martin to CEO, replacing David Brooks from Monday. Martin has been RM's CFO for five years. Mark Berry, who was CFO of estate agent Foxtons PLC, will join as interim CFO early next month until a permanent successor is found.

----------

Danakali Ltd - developing Colluli sulphate of potash project in Eritrea - Non-Executive Chair Seamus Cornelius moves to executive chair, as the role of CEO Niels Wage is made redundant and board members take a 33% cut in fees. Danakali says the board size will be reduced at its annual general meeting in the second quarter. Cites the "ongoing serious disruption to international travel caused by the Covid-19 pandemic", saying the changes will reduce operating costs.

----------

Universe Group PLC - Southampton, Hampshire-based retail management, payment and loyalty systems - CEO Jeremy Lewis will leave on April 30 "to pursue other opportunities outside of the public markets", after seven years with Universe. Says in discussions for a successor. Non-Executive Chair Andrew Blazye moves to executive chair, effective immediately, while Ivan Brooks takes on the new position of chief operations officer on an interim basis.

----------

Schroder UK Public Private Trust PLC - formerly Woodford Patient Capital Trust, invests in both listed and private UK companies - Hires Tim Edwards as an independent non-executive director, effective immediately, with the intention that he will replace retiring Susan Searle as chair at the next annual general meeting. Edwards is a chartered accountant who is an independent non-executive director of currency manager Record PLC, among other roles.

----------

Tissue Regenix Group PLC - Leeds-based medical devices for regenerative medicine - Confirms Interim Non-Executive Chair Jonathan Glenn as permanent chair, effective immediately. Glenn joined Tissue Regenix at the start of 2016 and was made interim chair back in March of last year.

----------

Arix Bioscience PLC - venture capital investment in biotech firms - Hires James Noble and Axel Wieandt as non-executive directors, starting April 1. Noble is lead independent director of former London-listing GW Pharmaceuticals, chair of Stockholm-listed Orexo AG, and a director of Nasdaq-listed Adaptimmune Therapeutics PLC, where he previously was CEO. Wieandt worked at Morgan Stanley and then Deutsche Bank AG, where he was head of Corporate Development and global head of Corporate Investments. He also was CEO of Hypo Real Estate. Meanwhile, Mark Breuer steps down from the Arix board on April 1, and Arix promotes Giles Kerr to senior independent director, effective immediately.

----------

Emis Group PLC - healthcare software - Hires Jayaprakasa Rangaswami as independent non-executive director, starting on Monday. Rangaswami is currently a non-executive director of publisher Daily Mail & General Trust PLC and insurer Admiral Group PLC. As an executive, he was chief data officer and head of innovation at Deutsche Bank AG.

----------

Zambeef Products PLC - Lusaka, Zambia-based beef producer - David Osborne steps down as director on Sunday following his retirement from shareholder CDC Group PLC.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
20 Jan 2016 08:43

Tissue Regenix Says DermaPure Surpasses USD1 Million Sales Mark

Read more
19 Jan 2016 08:52

Tissue Regenix Appoints Consort Medical CEO As Non-Executive Director

Read more
18 Jan 2016 08:42

Tissue Regenix Completes Enrolment For OrthoPure Trial

Read more
4 Dec 2015 09:04

Tissue Regenix Says First Two Patients Receive OrthoPure Tendons

Read more
23 Oct 2015 08:57

DIRECTOR DEALINGS: Tissue Regenix Non-Executive Buys 400,000 Shares

Read more
12 Oct 2015 08:53

Tissue Regenix First Half Loss Widens As It Rolls Out DermaPure

Read more
12 Oct 2015 05:47

GET READY: Jupiter Fund Management At 0700 BST

Read more
5 Oct 2015 14:59

Earnings, Trading Statements Calendar - Week Ahead

Read more
30 Jul 2015 09:41

Tissue Regenix Gets Further Medicare Coverage For DermaPure

Read more
22 Jul 2015 08:10

Tissue Regenix Signs Further DermaPure US Regional Distribution Deal

Read more
26 Jun 2015 11:14

LONDON MARKET MIDDAY: Tesco Cheers Market Suffering Greece Fatigue

Read more
26 Jun 2015 10:31

WINNERS & LOSERS: Tesco Goes "In Right Direction", Lifts Grocer Stocks

Read more
26 Jun 2015 08:47

Tissue Regenix Group gains further Medicare approval for DermaPure

Regenerative medical devices group Tissue Regenix has received approval for DermaPure(R) reimbursement from two further administrators of the Medicare health insurance programme in the US. The approval from the Noridian Healthcare Solutions and Palmetto GBA Medicare administrators means that DermaPu

Read more
26 Jun 2015 07:31

Tissue Regenix Gets Further Medicare Coverage Approval For DermaPure

Read more
1 Jun 2015 08:28

Tissue Regenix's DermaPure Featured In US Television Show

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.